These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27684341)

  • 1. Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.
    Trembizki E; Guy R; Donovan B; Kaldor JM; Lahra MM; Whiley DM;
    Lancet Infect Dis; 2016 Sep; 16(9):1005-1006. PubMed ID: 27684341
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciprofloxacin May be Efficacious in Treating Wild-Type Gyrase A Genotype Neisseria gonorrhoeae Infections.
    Allan-Blitz LT; Hemarajata P; Humphries RM; Kimble M; Elias S; Klausner JD
    Sex Transm Dis; 2018 Apr; 45(4):e18. PubMed ID: 29465685
    [No Abstract]   [Full Text] [Related]  

  • 3. Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.
    Allan-Blitz LT; Humphries RM; Hemarajata P; Bhatti A; Pandori MW; Siedner MJ; Klausner JD
    Clin Infect Dis; 2017 May; 64(9):1268-1270. PubMed ID: 28034887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E628-30. PubMed ID: 26779739
    [No Abstract]   [Full Text] [Related]  

  • 5. Sharp increase in ciprofloxacin resistance of
    Crucitti T; Belinga S; Fonkoua MC; Abanda M; Mbanzouen W; Sokeng E; Nzouankeu A
    Int J STD AIDS; 2020 May; 31(6):579-586. PubMed ID: 32316853
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial susceptibility profile of
    Affolabi D; Goma E; Sogbo F; Ahotin G; Orekan J; Massou F; Behanzin L; Guédou F; Alary M
    Sex Transm Infect; 2018 Feb; 94(1):20. PubMed ID: 29021407
    [No Abstract]   [Full Text] [Related]  

  • 7. Australian gonococcal surveillance programme, 1 April to 30 June 2014.
    Lahra MM;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E390-2. PubMed ID: 25631604
    [No Abstract]   [Full Text] [Related]  

  • 8. Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa.
    Moodley P; Moodley D; Willem Sturm A
    Int J Antimicrob Agents; 2004 Aug; 24(2):192-3. PubMed ID: 15288322
    [No Abstract]   [Full Text] [Related]  

  • 9. The Frequency of Discordant Gyrase A Genotypes Among Cases of Multiple Neisseria gonorrhoeae Infections at Different Anatomic Sites.
    Allan-Blitz LT; Ellis OL; Bolan R; Hemarajata P; Humphries RM; Shahkolahi A; McGrath M; Klausner JD
    Sex Transm Dis; 2019 Jan; 46(1):e3-e4. PubMed ID: 30216232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Mar; 40(1):E179-81. PubMed ID: 27080026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characterization of highly fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Viscaya].
    Alkorta M; Urra E; Hernández JL; Bilbao R
    Enferm Infecc Microbiol Clin; 2008 Jan; 26(1):60-1. PubMed ID: 18208770
    [No Abstract]   [Full Text] [Related]  

  • 12. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016
.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E109-E110. PubMed ID: 28385144
    [No Abstract]   [Full Text] [Related]  

  • 13. Future treatment of gonorrhea--novel emerging drugs are essential and in progress?
    Unemo M; Shafer WM
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):357-60. PubMed ID: 25907334
    [No Abstract]   [Full Text] [Related]  

  • 14. A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.
    Allan-Blitz LT; Hemarajata P; Humphries RM; Wynn A; Segura ER; Klausner JD
    Sex Transm Dis; 2018 Feb; 45(2):87-91. PubMed ID: 29329176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects of untreatable gonorrhea and ways forward.
    Whiley DM; Lahra MM; Unemo M
    Future Microbiol; 2015; 10(3):313-6. PubMed ID: 25812453
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology.
    Zhou W; Du W; Cao H; Zhao J; Yang S; Li W; Shen Y; Zhang S; Du W; Zhang X
    J Clin Microbiol; 2004 Dec; 42(12):5819-24. PubMed ID: 15583317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin resistance in Neisseria gonorrhoeae: trends in Hawaii, 1997-2002.
    Katz AR; Lee MV; Ohye RG; Whiticar PM; Effler PV
    Lancet; 2003 Aug; 362(9382):495. PubMed ID: 12927447
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial susceptibility and genotypic distribution of Neisseria gonorrhoeae: a 2-year study in Tunisia.
    Ferjani A; Marzouk M; Saghrouni F; Hadj Ali M; Boukadida J
    Med Mal Infect; 2013 May; 43(5):211-2. PubMed ID: 23623306
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].
    Koedijk FD; van den Broek I; Stirbu-Wagner I; van Bergen JE
    Ned Tijdschr Geneeskd; 2013; 157(24):A5642. PubMed ID: 23759175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.
    Allan-Blitz LT; Wang X; Klausner JD
    Sex Transm Dis; 2017 May; 44(5):261-265. PubMed ID: 28407640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.